Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.53T
24h Vol:
$9.62B
Dominance:
MSFT:5.17%
Stocklytics Platform
BETA
Instrument logo  BDX

Becton Dickinson and Co

BDX
60 / 100
S&P500
$241.72arrow_drop_down-1.81%-$4.48
Key Stats
Open$245.87
Prev. Close$246.20
EPS4.36
Dividend$3.68
Next Earnings DateJun 28, 2024
Dividend Yield %1.54%
Market Cap$69.96B
PE Ratio55.52
LOWHIGH
Day Range241.89
246.24
52 Week Range228.61
287.32
Ratios
P/B Ratio2.81
Revenue$19.37B
Operating M. %10.69%
Earnings$1.53B
Earnings Growth %-14.00%
EBITDA Margin %25.36%
ROE %5.13%
EPS4.36
Fundamentals
RPS$67.72
Gross Profit$8.17B
EBITDA$4.66B
Total Debt$16.11B
P/S Ratio3.6x
Enterprise to EBITDA20.09
Profit Margin6.44%
ROA3.12%
Debt/Equity Ratio0.64%
Payout Ratio31.21%
Industry average yield3.02%
Last Dividend pay dateMar 29, 2024
Dividend per share$3.68
Dividend yield forecast0.02%

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

BDXarrow_drop_down-1.67%
US Healthcare Sectorarrow_drop_up0.43%
US Marketarrow_drop_down-1.23%
BDX / Market
BDX lose to the US Market which returned -1.23% over the last twenty four hours.
BDX / Healthcare Sector
BDX lose to the US Healthcare sector which returned 0.43% over the last twenty four hours.

Becton Dickinson and Co (BDX) Statistics

Becton Dickinson and Co (BDX) is a leading medical technology company that specializes in the development, manufacture, and sale of innovative healthcare products. As of the latest valuation metrics, BDX has a market capitalization of $70.5 billion. The stock is evaluated based on various key financial indicators to assess its overall value. BDX has a forward price-to-earnings ratio of 19.8, indicating reasonable valuation. The price-to-sales ratio stands at 2.9, suggesting that the stock is trading at a moderate multiple of its revenue. BDX also has a price-to-book value ratio of 3.4, indicating that the stock is trading at a slight premium to its book value.

When it comes to fundamentals, BDX has a solid track record. The company has consistently delivered revenue growth, with a revenue per share of $37.2. This demonstrates its ability to generate substantial sales per outstanding share. BDX also boasts a healthy profit margin of 12.6%, indicating its efficiency in translating revenue into profit. Furthermore, the company has managed its debt levels prudently, with a total debt of $18.2 billion. This suggests that BDX has a manageable level of debt relative to its overall financial position. Additionally, BDX has a strong gross profit of $8.9 billion, highlighting its ability to generate profits after accounting for the cost of goods sold.

add Becton Dickinson and Co to watchlist

Keep an eye on Becton Dickinson and Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
How has Becton Dickinson and Co (BDX) stock's performance compared to its sector and the market over the past year?

Over the past year, Becton Dickinson and Co (BDX) has experienced a price change of 2.2%. Compared to the Healthcare sector, which saw a change of 33.39%, Becton Dickinson and Co has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 39.27%, it has fallen short of the market average. This comparison highlights Becton Dickinson and Co's performance relative to both its sector and the overall market over the last year.

question_mark
What is the PE ratio of Becton Dickinson and Co (BDX) stock?

The PE (Price to Earnings) ratio of Becton Dickinson and Co (BDX) is currently 55.52. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

question_mark
What is the EPS of Becton Dickinson and Co (BDX) stock?

The Earnings Per Share (EPS) for Becton Dickinson and Co (BDX), calculated on a diluted basis, is $4.36. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

question_mark
What is the operating margin of Becton Dickinson and Co (BDX) stock?

The operating margin for Becton Dickinson and Co (BDX) is 10.69%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

question_mark
What is the EBITDA of Becton Dickinson and Co (BDX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Becton Dickinson and Co (BDX) is $4.67B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

question_mark
How much debt does Becton Dickinson and Co (BDX) have?

Becton Dickinson and Co (BDX) has a total debt of $16.11B. The net debt, which accounts for cash and cash equivalents against the total debt, is $14.93B.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.